BVMF/E1WL34 (BVMF/E1WL34)

Brazil Stock Exchange: BVMF/E1WL34 · BRL

R$105

-9.46 (-8.3%)· Recorded snapshot

Market cap	279.9B
Revenue (ttm)	33.7B
Net income (ttm)	5.2B
EPS (ttm)	R$2.29
P/E (trailing)	45.6x
P/E (forward)	29.0x
Volume	7
Beta	0.86

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 33.7B
Net income (ttm): 5.2B
EPS (ttm): R$2.29
P/E (trailing): 45.6x
P/E (forward): 29.0x
Market cap: 279.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E29

P25 n/aP50 n/aP75 n/a

Trailing P/E45.6

P25 n/aP50 n/aP75 n/a

ROE9.2

P25 n/aP50 n/aP75 n/a

ROIC17.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/E1WL34 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-04
Employees	16,000
Employees change	-4,000
Employees growth	-20.2%
Enterprise value	BRL 261.4B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1958
Industry	Medical Devices
Is primary listing	No
ISIN number	BRE1WLBDR000
Last earnings date	2026-07-23
Last refreshed	2026-10-28
Last stock split date	2020-06-01
Last stock split type	Forward
Market cap	BRL 279.9B
Next earnings date	2026-11-04
Price	BRL 104.50
Price currency	BRL
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-09
Symbol	bvmf/E1WL34
Website	https://www.edwards.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	40.97x
Average P/E ratio (3Y)	29.63x
Average P/E ratio (5Y)	34.28x
Earnings yield	2.19%
EV/Earnings	50.2x
EV/EBIT	26.69x
EV/EBITDA	24.12x
EV/FCF	35.19x
EV/Sales	7.51x
FCF / EV yield	2.84%
FCF yield	2.65%
Forward P/E	29.01x
Graham number	30.11943
Graham upside	-71.18%
Lynch fair value	BRL 9.72
Lynch upside	-90.7%
P/(FCF - SBC) ratio	42.69x
P/(OCF - SBC) ratio	34.81x
P/B ratio	5.04x
P/E ratio	45.58x
P/FCF ratio	37.69x
P/OCF ratio	31.41x
P/S ratio	8.3x
Price / tangible book value	7.42x
Price/EBITDA ratio	27.06x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	28.12%
EBITDA margin	30.66%
Effective tax rate	30.97%
FCF margin	21.38%
Gross margin	77.84%
Operating margin	28.12%
Pretax margin	21.77%
Profit margin	15.43%
Profit per employee	BRL 325,387
Profitable quarters	24
Profitable years	24
Revenue per employee	BRL 2.1M
ROA	8.37%
ROA (5Y)	10.1%
ROCE	14.82%
ROE	9.18%
ROE (5Y)	19.62%
ROIC	17.39%
ROIC (5Y)	24.51%
SBC / revenue	2.58%
Tax / revenue	6.74%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-75.5%
EPS growth (Q)	-25.39%
EPS growth (QoQ)	-36.15%
EPS growth 10Y	7.86%
EPS growth 3Y	-8.78%
EPS growth 5Y	-5.69%
EPS growth years	0
FCF growth	143.85%
FCF growth (Q)	142.84%
FCF growth 3Y	26.86%
FCF growth 5Y	6.41%
Gross profit growth	13.05%
Gross profit growth (Q)	13.54%
Gross profit growth 3Y	6.63%
Gross profit growth 5Y	6.38%
Net income growth	-75.77%
Net income growth (Q)	-27.4%
Net income growth (QoQ)	-36.46%
Net income growth 3Y	-10.24%
Net income growth 5Y	-7.23%
Net income growth years	0
OCF growth	116.42%
OCF growth (Q)	124.64%
OCF growth (QoQ)	1,388.36%
OCF growth 10Y	11.04%
OCF growth 3Y	22.3%
OCF growth 5Y	3.59%
Operating income growth	15.25%
Operating income growth (Q)	20.56%
Operating income growth 3Y	7.13%
Operating income growth 5Y	3.45%
Revenue growth	14.55%
Revenue growth (Q)	13.63%
Revenue growth (QoQ)	5.6%
Revenue growth 10Y	9.03%
Revenue growth 3Y	8.02%
Revenue growth 5Y	5.75%
Revenue growth quarters	9
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -1.5B
Depreciation and amortization	BRL 883M
EBIT	BRL 9.5B
EBITDA	BRL 10.3B
EPS	BRL 2.29
Financing cash flow	BRL -6.2B
Free cash flow	BRL 7.4B
Free cash flow minus SBC	BRL 6.6B
Gross profit	BRL 26.3B
Income taxes	BRL 2.3B
Investing cash flow	BRL -4.7B
Net cash flow	BRL -2B
Net income	BRL 5.2B
Operating cash flow minus SBC	BRL 8B
Operating income	BRL 9.5B
Revenue	BRL 33.7B
Stock-based compensation	BRL 870.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.92
Book value per share	BRL 95.40
Debt / EBITDA	0.35
Debt / equity	0.07
Debt / FCF	0.49
Goodwill	BRL 10.4B
Interest coverage	89.77
Long-term assets	BRL 35.5B
Long-term liabilities	BRL 8.2B
Net cash (debt)	BRL 18.5B
Net cash / market cap	6.62%
Net cash growth	6.31%
Net debt / EBITDA	-1.79
Net debt / equity	-0.33
Net debt / FCF	-2.5
Piotroski F-Score	4
Property, plant and equipment	BRL 10.4B
Shareholders' equity	BRL 55.6B
Tangible book value	BRL 37.7B
Tangible book value per share	BRL 65.45
Total assets	BRL 71.8B
Total cash	BRL 22B
Total debt	BRL 3.6B
Total liabilities	BRL 16.3B
WACC	8.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current assets	BRL 36.4B
Current liabilities	BRL 8B
Current ratio	4.52
Inventory turnover	1.27
Net working capital	BRL 5.6B
Quick ratio	3.45
Working capital	BRL 27.5B
Working capital turnover	6.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.64%
Shareholder yield	1.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 108.51
1D price change	-8.3%
1M price change	-1.14%
1M total return	-1.14%
1W price change	-8.3%
1W total return	-8.3%
1Y price change	4.29%
1Y return CAGR	4.29%
1Y total return	4.29%
20-day SMA	BRL 110.73
200-day SMA	BRL 107.91
3M price change	-13.43%
3M total return	-13.43%
3Y price change	9.68%
3Y return CAGR	3.13%
3Y total return	9.68%
50-day SMA	BRL 107.10
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 122.51
52-week high date	2026-07-06
52-week low	BRL 94.30
52-week low date	2026-05-11
5Y price change	-30.19%
5Y return CAGR	-6.94%
5Y total return	-30.19%
6M price change	-0.09%
6M total return	-0.09%
All-time high	BRL 185.90
All-time high date	2021-12-29
All-time low	BRL 75.10
All-time low date	2020-02-28
Average true range (ATR)	BRL 2.89
Average volume	156.3
Beta (5Y)	0.86
Change from 52-week high	-14.7%
Change from 52-week low	10.82%
Change from all-time high	-43.79%
Change from all-time low	39.14%
Change from open	0%
Day's gap	-8.3%
Dollar volume	BRL 732
High price	BRL 104.50
Low price	BRL 104.50
Monthly RSI	48.15
Open price	BRL 104.50
Previous close	BRL 113.96
Price vs 150-day SMA	-3.69%
Price vs 20-day SMA	-5.63%
Price vs 200-day SMA	-3.16%
Price vs 50-day SMA	-2.43%
Relative volume	0.04
RSI	43.08
Sharpe ratio	-0.15
Sharpe ratio (3Y)	0.07
Sortino ratio	-0.01
Sortino ratio (3Y)	0.24
Volume	7
Weekly RSI	47.28
YTD price change	-12.04%
YTD total return	-12.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	574.5M
Shares change (QoQ)	-0.53%
Shares change (YoY)	-1.64%
Shares held by insiders	0.22%
Shares held by institutions	92.86%
Short ratio	2.8 days

Deeper analysis on BVMF/E1WL34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/E1WL34 report

Is a complete BVMF/E1WL34 research report available?

No complete published report is available for bvmf/E1WL34 (BVMF/E1WL34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/E1WL34 (BVMF/E1WL34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/E1WL34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/E1WL34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/E1WL34

Frequently asked questions